
Gsk Buildcon Private Limited
Founded in 2011 and headquartered in Delhi, India.
Founded in 2011 and headquartered in Delhi, India.
Delhi, India
+91-XXXXXXXXXX
-
U70200DL2011PTC214255
214255
Private Limited Indian Non-Government Company
17 Feb 2011
30 Sep 2017
31 Mar 2017
Unlisted
Roc Delhi
Name | Designation | Appointment Date | Status |
---|---|---|---|
Satyam Jagatramka ![]() | Director | 17-Feb-2011 | Current |
Gourish Jagatramka ![]() | Director | 17-Feb-2011 | Current |
Gsk Buildcon Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
In 2017, Gsk Buildcon had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Satyam Jagatramka is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Gsk Buildcon, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Gsk Buildcon, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gsk Buildcon's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Gsk Buildcon Private Limited last Annual general meeting of members was held on 30 Sep 2017 as per latest MCA records.
Gsk Buildcon Private Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Delhi.
Satyam Jagatramka was appointed as a Director was appointed as a Director on 17 Feb 2011 & has been associated with this company since 14 years 15 days .
Gourish Kumar Jagatramka was appointed as a Director was appointed as a Director on 17 Feb 2011 & has been associated with this company since 14 years 15 days .
Gsk Buildcon Private Limited was registered on 17 Feb 2011 with Roc Delhi & aged 14 years 15 days as per MCA records.
Gsk Buildcon Private Limited was incorporated on 17 Feb 2011.
The authorized share capital of Gsk Buildcon Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Gsk Buildcon Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Gsk Buildcon Private Limited is X/50 1St Floor Pratap Gali, Gandhi Nagar India, Delhi, 110031.
The corporate identification number (CIN) of Gsk Buildcon Private Limited is U70200DL2011PTC214255 and the company number is 214255 as per Ministry of Corporate Affairs (MCA).
The most recent Balance Sheet for Gsk Buildcon Private Limited was filed with the ROC on 31 Mar 2017.